tradingkey.logo

Molecular Partners Presents Data From Ongoing Phase 1/2A Trial Of Mp0533 In Aml At EHA 2025

ReutersJun 11, 2025 8:04 PM

- Molecular Partners AG MOLN.S:

  • MOLECULAR PARTNERS PRESENTS POSITIVE DATA FROM ONGOING PHASE 1/2A TRIAL OF MP0533 IN AML AT EHA 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI